Exact Mass: 416.2093
Exact Mass Matches: 416.2093
Found 277 metabolites which its exact mass value is equals to given mass value 416.2093
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Spironolactone
Latex as found in nature is a milky fluid found in 10\\\% of all flowering plants (angiosperms). It is a complex emulsion consisting of proteins, alkaloids, starches, sugars, oils, tannins, resins, and gums that coagulates on exposure to air. It is usually exuded after tissue injury. In most plants, latex is white, but some have yellow, orange, or scarlet latex. Since the 17th century, latex has been used as a term for the fluid substance in plants. It serves mainly as defense against herbivorous insects. Many people are allergic to latex. [Wikipedia]. A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents > C03DA - Aldosterone antagonists C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics CONFIDENCE standard compound; EAWAG_UCHEM_ID 2902 Spironolactone. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=52-01-7 (retrieved 2024-10-11) (CAS RN: 52-01-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Ethyl 7-epi-12-hydroxyjasmonate glucoside
Ethyl 7-epi-12-hydroxyjasmonate glucoside is found in herbs and spices. Ethyl 7-epi-12-hydroxyjasmonate glucoside is a constituent of sage (Salvia officinalis) Constituent of sage (Salvia officinalis). Ethyl 7-epi-12-hydroxyjasmonate glucoside is found in herbs and spices.
ZANOTERONE
6-Acetoxy-7-hydroxymyrcene-7-O-beta-D-glucopyranoside-2-O-acetate
(5R,8Z,11Z)-5-beta-D-glucopyranosyloxy-6-oxotetradeca-8,11-dienoic acid
8-O-(2,6-Diacetyl-beta-D-glucopyranoside)-(E)-2-Methyl-6-methylene-2-octene-1,8-diol
5-acetoxy-2,6-dimethyl-3-hydroxymethyl-1,6-heptadiene-9-O-(6-acetyl-beta-D-glucopyranoside)
9-acetoxy-gamma-geraniol-(6-acetyl-beta-D-glucopyranoside)
C20H32O9_(1beta,2alpha,4xi,5xi,9xi,11alpha,12alpha,13xi,15beta)-1,2,4,11,12,14,15-Heptahydroxypicrasan-16-one
Spironolactone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents > C03DA - Aldosterone antagonists C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ala Ala Gln Gln
Ala Gly Asn Arg
Ala Gly Arg Asn
Ala Met Pro Val
Ala Met Val Pro
Ala Asn Gly Arg
Ala Asn Asn Val
Ala Asn Arg Gly
Ala Asn Val Asn
Ala Pro Met Val
Ala Pro Val Met
Ala Gln Ala Gln
Ala Gln Gln Ala
Ala Arg Gly Asn
Ala Arg Asn Gly
Ala Val Met Pro
Ala Val Asn Asn
Ala Val Pro Met
Cys Pro Val Val
Cys Val Pro Val
Cys Val Val Pro
Phe Gly Pro Pro
Phe Pro Gly Pro
Phe Pro Pro Gly
Gly Ala Asn Arg
Gly Ala Arg Asn
Gly Phe Pro Pro
Gly Gly Gln Arg
Gly Gly Arg Gln
Gly Ile Met Pro
Gly Ile Asn Asn
Gly Ile Pro Met
Gly Leu Met Pro
Gly Leu Asn Asn
Gly Leu Pro Met
Gly Met Ile Pro
Gly Met Leu Pro
Gly Met Pro Ile
Gly Met Pro Leu
Gly Asn Ala Arg
Gly Asn Ile Asn
Gly Asn Leu Asn
Gly Asn Asn Ile
Gly Asn Asn Leu
Gly Asn Gln Val
Gly Asn Arg Ala
Gly Asn Val Gln
Gly Pro Phe Pro
Gly Pro Ile Met
Gly Pro Leu Met
Gly Pro Met Ile
Gly Pro Met Leu
Gly Pro Pro Phe
Gly Gln Gly Arg
Gly Gln Asn Val
Gly Gln Arg Gly
Gly Gln Val Asn
Gly Arg Ala Asn
Gly Arg Gly Gln
Gly Arg Asn Ala
Gly Arg Gln Gly
Gly Val Asn Gln
Gly Val Gln Asn
Ile Gly Met Pro
Ile Gly Asn Asn
Ile Gly Pro Met
Ile Met Gly Pro
Ile Met Pro Gly
Ile Asn Gly Asn
Ile Asn Asn Gly
Ile Pro Gly Met
Ile Pro Met Gly
Leu Gly Met Pro
Leu Gly Asn Asn
Leu Gly Pro Met
Leu Met Gly Pro
Leu Met Pro Gly
Leu Asn Gly Asn
Leu Asn Asn Gly
Leu Pro Gly Met
Leu Pro Met Gly
Met Ala Pro Val
Met Ala Val Pro
Met Gly Ile Pro
Met Gly Leu Pro
Met Gly Pro Ile
Met Gly Pro Leu
Met Ile Gly Pro
Met Ile Pro Gly
Met Leu Gly Pro
Met Leu Pro Gly
Met Pro Ala Val
Met Pro Gly Ile
Met Pro Gly Leu
Met Pro Ile Gly
Met Pro Leu Gly
Met Pro Val Ala
Met Val Ala Pro
Met Val Pro Ala
Asn Ala Gly Arg
Asn Ala Asn Val
Asn Ala Arg Gly
Asn Ala Val Asn
Asn Gly Ala Arg
Asn Gly Ile Asn
Asn Gly Leu Asn
Asn Gly Asn Ile
Asn Gly Asn Leu
Asn Gly Gln Val
Asn Gly Arg Ala
Asn Gly Val Gln
Asn Ile Gly Asn
Asn Ile Asn Gly
Asn Leu Gly Asn
Asn Leu Asn Gly
Asn Asn Ala Val
Asn Asn Gly Ile
Asn Asn Gly Leu
Asn Asn Ile Gly
Asn Asn Leu Gly
Asn Asn Val Ala
Asn Gln Gly Val
Asn Gln Val Gly
Asn Arg Ala Gly
Asn Arg Gly Ala
Asn Val Ala Asn
Asn Val Gly Gln
Asn Val Asn Ala
Asn Val Gln Gly
Pro Ala Met Val
Pro Ala Val Met
Pro Cys Val Val
Pro Phe Gly Pro
Pro Phe Pro Gly
Pro Gly Phe Pro
Pro Gly Ile Met
Pro Gly Leu Met
Pro Gly Met Ile
Pro Gly Met Leu
Pro Gly Pro Phe
Pro Ile Gly Met
Pro Ile Met Gly
Pro Leu Gly Met
Pro Leu Met Gly
Pro Met Ala Val
Pro Met Gly Ile
Pro Met Gly Leu
Pro Met Ile Gly
Pro Met Leu Gly
Pro Met Val Ala
Pro Pro Phe Gly
Pro Pro Gly Phe
Pro Val Ala Met
Pro Val Cys Val
Pro Val Met Ala
Pro Val Val Cys
Gln Ala Ala Gln
Gln Ala Gln Ala
Gln Gly Gly Arg
Gln Gly Asn Val
Gln Gly Arg Gly
Gln Gly Val Asn
Gln Asn Gly Val
Gln Asn Val Gly
Gln Gln Ala Ala
Gln Arg Gly Gly
Gln Val Gly Asn
Gln Val Asn Gly
Arg Ala Gly Asn
Arg Ala Asn Gly
Arg Gly Ala Asn
Arg Gly Gly Gln
Arg Gly Asn Ala
Arg Gly Gln Gly
Arg Asn Ala Gly
Arg Asn Gly Ala
Arg Gln Gly Gly
Val Ala Met Pro
Val Ala Asn Asn
Val Ala Pro Met
Val Cys Pro Val
Val Cys Val Pro
Val Gly Asn Gln
Val Gly Gln Asn
Val Met Ala Pro
Val Met Pro Ala
Val Asn Ala Asn
Val Asn Gly Gln
Val Asn Asn Ala
Val Asn Gln Gly
Val Pro Ala Met
Val Pro Cys Val
Val Pro Met Ala
Val Pro Val Cys
Val Gln Gly Asn
Val Gln Asn Gly
Val Val Cys Pro
Val Val Pro Cys
Ethyl 7-epi-12-hydroxyjasmonate glucoside
1-N-BOC-4-(3-ETHOXYCARBONYLMETHYL-4-OXO-3,4-DIHYDRO-QUINAZOLIN-6-YL)PIPERAZINE
zanoterone
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
(S)-BENZYL 5-AMINO-2-(DIBENZYLAMINO)-5-OXOPENTANOATE
3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-tert-butoxycarbonylaminopiperidin-1-yl)-xanthine
N-(1,3-Benzodioxol-5-Ylmethyl)-1-[(1r)-1-Naphthalen-1-Ylethyl]piperidine-4-Carboxamide
[3-(3-carbamoylphenyl)phenyl] N-(6-phenylhexyl)carbamate
N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide
N1-citryl-N3-decanoyl-N3-hydroxy-1,3-diaminopropane
2-[2-[3-[[(E)-dec-2-enoyl]-hydroxyamino]propylamino]-2-oxoethyl]-2-hydroxybutanedioic acid
N-(2H-1,3-benzodioxol-5-ylmethyl)-1-[(1S)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide (I-4)
1-[2-(4-Methylphenyl)sulfanylethyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,2-oxazole-5-carboxamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,2-oxazole-5-carboxamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,2-oxazole-5-carboxamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,2-oxazole-5-carboxamide
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(3-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-cyclopropylethanone
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-4-(1-oxo-2-phenylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-4-(1-oxo-2-phenylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-4-(2-cyclopropylacetyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-4-(2-cyclopropylacetyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-cyclobutylmethanone
(6S,7R,8S)-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-4-(1-oxo-2-phenylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-4-(1-oxo-2-phenylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-4-(1-oxo-2-phenylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-4-(1-oxo-2-phenylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-4-(1-oxo-2-phenylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-4-(1-oxo-2-phenylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-4-(2-cyclopropylacetyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-4-(2-cyclopropylacetyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-4-(2-cyclopropylacetyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-4-(2-cyclopropylacetyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
Duraspiron
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics